These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23585159)

  • 1. Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls.
    Martino ME; de Villoria JG; Lacalle-Aurioles M; Olazarán J; Cruz I; Navarro E; García-Vázquez V; Carreras JL; Desco M
    Ann Nucl Med; 2013 Aug; 27(7):600-9. PubMed ID: 23585159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
    Della Rosa PA; Cerami C; Gallivanone F; Prestia A; Caroli A; Castiglioni I; Gilardi MC; Frisoni G; Friston K; Ashburner J; Perani D;
    Neuroinformatics; 2014 Oct; 12(4):575-93. PubMed ID: 24952892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints.
    Van Der Gucht A; Verger A; Yagdigul Y; Poussier S; Joly L; Watfa G; Benetos A; Karcher G; Marie PY
    Acta Radiol; 2015 Aug; 56(8):980-9. PubMed ID: 25085109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis.
    Van Der Gucht A; Verger A; Guedj E; Malandain G; Hossu G; Yagdigul Y; Roch V; Poussier S; Maillard L; Karcher G; Marie PY
    Ann Nucl Med; 2015 Dec; 29(10):921-8. PubMed ID: 26323854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.
    Pagani M; De Carli F; Morbelli S; Öberg J; Chincarini A; Frisoni GB; Galluzzi S; Perneczky R; Drzezga A; van Berckel BN; Ossenkoppele R; Didic M; Guedj E; Brugnolo A; Picco A; Arnaldi D; Ferrara M; Buschiazzo A; Sambuceti G; Nobili F
    Neuroimage Clin; 2015; 7():34-42. PubMed ID: 25610765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.
    Verger A; Yagdigul Y; Van Der Gucht A; Poussier S; Guedj E; Maillard L; Malandain G; Hossu G; Fay R; Karcher G; Marie PY
    Ann Nucl Med; 2016 May; 30(4):272-8. PubMed ID: 26841946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
    Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
    Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A statistical parametric mapping toolbox used for voxel-wise analysis of FDG-PET images of rat brain.
    Nie B; Liu H; Chen K; Jiang X; Shan B
    PLoS One; 2014; 9(9):e108295. PubMed ID: 25259529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
    Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
    Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysis.
    Gallivanone F; Della Rosa PA; Perani D; Gilardi MC; Castiglioni I;
    Q J Nucl Med Mol Imaging; 2017 Mar; 61(1):115-132. PubMed ID: 25479418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analytic comparison between PIB-PET and FDG-PET results in Alzheimer's disease and MCI.
    He W; Liu D; Radua J; Li G; Han B; Sun Z
    Cell Biochem Biophys; 2015 Jan; 71(1):17-26. PubMed ID: 25370296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.